Delivery Order SPE2DB22D1106-SPE2DB25FEFC4
Award Date
3/27/25
Potential Completion Date
3/28/25
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $7,170.89 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Exforge 5-320 mg tablets, with a period of performance through April 15, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,401.85 delivery order contract is for the delivery of Exforge 10-320 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of August 30, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,570.80, is a delivery order for Exforge 10-320 mg tablets, with an ultimate completion date of April 10, 2025. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Exforge 5-160 mg tablets. The $2,797.79 firm fixed-price contract has a period of performance through February 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Exforge 10-320 mg tablet 30s. The contract has a ceiling value of $1,735.10 and a period of performance through April 16, 2025. This award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which provides a...
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,058.36, is for the delivery of Exforge 5-320 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of March 17, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, with ID SPE2DB22D2009|SPE2DB24FM0YE, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,481.36 firm fixed-price contract is for the delivery of Exforge 10-320 mg tablets. The contract is not designated under any set-aside program. It is a delivery order awarded under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division for the procurement of Exforge 10-160 mg tablets. The order, valued at $4,515.18, is a firm fixed-price contract with a completion date of May 23, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $15,834.87, is a Delivery Order contract for Exforge 10-320 mg tablets. The contract has an ultimate completion date of October 31, 2024 and a firm fixed price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a delivery order with a ceiling value of $13,310.45 for the supply of the drug Exforge 10-160 mg tablets. The contract is a firm fixed price arrangement, with an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp holds an Indefinite...